Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities

Current Pharmaceutical Design

Volumn 10, Issue 30, 2004, Pages 3813-3833

  Fylaktakidou, Konstantina C ^a   Hadjipavlou Litina, Dimitra J ^b   Litinas, Konstantinos E ^b   Nicolaides, Demetrios N ^b  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Antiinflammatories; Antioxidants; Natural coumarins; Synthetic coumarins

Indexed keywords

4 HYDROXYCOUMARIN; ACETYLSALICYLIC ACID; ANGELICIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CLORICROMEN; COUMARIN; COUMARIN DERIVATIVE; DAPHNETIN; ESCULETIN; ESCULIN; FLUFENAMIC ACID; HERNIARIN; HYMECROMONE; INDOMETACIN; ISOSCOPOLETIN; LIPOXYGENASE; METHOXSALEN; NORDIHYDROGUAIARETIC ACID; OSTHOLE; PHENYLBUTAZONE; PLANT EXTRACT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PSORALEN; PYRANOCOUMARIN DERIVATIVE; SCOPARONE; SCOPOLETIN; UMBELLIFERONE; UNINDEXED DRUG;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIS; DOSE RESPONSE; DRUG DESIGN; DRUG EFFICACY; DRUG ISOLATION; DRUG MIXTURE; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; EDEMA; ENZYME INHIBITION; INFLAMMATION; NONHUMAN; PAW EDEMA; PERITONITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; COUMARINS; HUMANS; INFLAMMATION; MOLECULAR STRUCTURE; PLANT EXTRACTS; PLANTS, MEDICINAL; REACTIVE OXYGEN SPECIES;

EID: 6944222563     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043382710     Document Type: Review

References (87)

1. Dannhardt G, Kiefer W. Cyclooxygenase inhibitors-current status and future prospects. Eur J Med Chem 2001; 36: 109-126.
2. Murray RDH, Mendez J, Brown RA. In: The Natural Coumarins. New York, J. Wiley & Sons, 1982.
3. Murray RDH. In: Herz W, Kirby GW, Steglich W, Tamm C Ed, Progress in the Chemistry of Organic Natural Products. Coumarins. New York, Springer-Verlag. 1991; Vol 58: 84-316.
4. Casley-Smith JR, Foldi-Borscsok E, Foldi M. The electron microscopy of the effect of treatment with coumarin (Venalot) and by thoracic dust cannulation on thermal injuries. Br J Exp Pathol 1973; 54: 1-5.
5. Casley-Smith JR, Casley-Smith JR. In: High protein oedemas and the benzopyrones. Sydney, J. B. Lippincott, 1986.
6. Casley-Smith JR, Casley-Smith JR. Modern treatment of lymphoedema II. The benzopyrones. Austral J Dermatol 1992; 33: 69-74.
7. Casley-Smith JR, Window J. Quantitative morphological correlations of alterations in capillary permeability, following histamine and moderate burning, in the mouse diaphragm, and the effects of benzopyrones. Microvasc Res 1976; 11: 279-305.
8. Casley-Smith JR, Foldi-Borcsok E, Foldi M. Fine structural aspects of lymphoedema in various tisues and the effect of treatment with coumarin and troxerutin. Br J Exp Pathol 1974; 55: 89-93.
9. Casley-Smith JR. Gaffney RM. Excess plasma proteins as a cause of chronic inflammation and lymphoedema: quantitative electron microscopy. J Pathol 1981; 133: 69-74.
10. Paya M, Halliwell B, Hoult JRS. Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem Pharmacol 1992; 44: 205-214.
11. Paya M, Goodwin PA, de las Heras B, Hoult JRS. Superoxide scavenging activity in leukocytes and absence of cellular toxicity of a series of coumarins. Biochem Pharmacol 1994; 48: 445-451.
12. Hoult JRS, Forder RA, De las Heras B, Lobo IB, Paya M. Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation. Agents Actions 1994; 42: 44-49.
13. Pasanen M, Rannala Z, Tooming A, Sotaniemi EA, Pelkonen O, Rautio A, Hepatitis A impairs the function of human hepatic CYP2A6 in vivo. Toxicology 1997; 123: 177-184.
14. Hardt TJ, Ritshel WA. Investigation of the Dose-Response Relationship upon Intraperitoneal Administration of Coumarin and 7-Hydroxycoumarin on the Carrageenan Induced Edema of the Rats Hind Paw. Arzneim-Forsch/Drug Res 1983; 33(II): 1662-1666.
15. Foldi-Borcsok VE, Bedall FK, Rahlfs VW. Die antiphlogistische und odemhemmende Wirkung von Cumarin aus Melilotus officinalis. Arzneim-Forsch/Drug Res 1971; 21: 2025-2030.
16. Leal LKAM, Matos ME, Ribeiro RA, Ferreira FV, Viana GSB. Antinociceptive and antiedematogenic effects of the hydroalcoholic extract and coumarin from Torresea cearensis. Phytomedicine 1997; 4: 221-227; Chem Abstrs 1998; 128, 39440e.
17. Shimizu M, et al. Anti-inflammatory Constituents of Topically Applied Crude Drugs. IV. Constituents and Anti-inflammatory Effect of Paraguayan Crude Drug "Alhucema" (Lavandula latifolia VILL). Chem Pharm Bull 1990; 38: 2283-2284.
18. Lino CS, Taveira ML, Viana GSB, Matos FJA. Analgesic and Anti-inflammatory Activities of Justicia pectoralis Jacq and its Main Constituents: Coumarin and Umbelliferone. Phytotherapy Research 1997; 11: 211-215.
19. Sekiya K, Okuda H, Arichi S. Selective inhibition of platelet lipoxygenase by esculetin. Biochimic. Biophys. Acta (BBA)-Lipids and Lipid Metabolism 1982; 713: 68-72.
20. Lee RE, Bykadi G, Ritschel WA. Inhibition of prostaglandin biosynthesis by coumarin, 4-hydroxycoumarin and 7-hydroxycoumarin. Arzneim-Forsch/Drug Res 1981; 31: 640-642.
21. Hoult JRS, Paya M. Pharmacological and Biochemical Actions of Simple Coumarins: Natural Products with Therapeutic Potential. Gen Pharmac 1996; 27: 713-722.
22. Alami I, Jouy N, Clerivet A. The Lipoxygenase Pathway is Involved in Elicitor-induced Phytoalexin Accumulation in Plane Tree (Platanus acerifolia) Cell-suspension Cultures. J Phytopathology 1999; 147: 515-519.
23. Erazo S, Garcia R, Backhouse N, Lemus I. Delporte C. Andrade C. Phytochemical and biological study of Radal Lomatia hirsuta (Proteaceae). J Ethnopharmacology 1997; 57: 81-83.
24. Zhu H, Huang J. Anti-inflammatory effect of scopoletin. Zhongcaoyao 1989; 15: 462-465; Chem Abstrs 1989; 102, 72550b.
25. Silvan AM, Abad MJ, Bermejo P, Sollhuber M, Villar A. Antiinflammatory Activity of Coumarins from Santolina oblongifolia. J Nat Prod 1996; 59: 1183-1185.
26. Delporte C, et al. Antipyretic, Hypothermic and Anti-inflammatory Activities and Metabolites from Solanum ligustrinum Lood. Phytother Res 1998; 12: 118-122.
27. Kostova I, Fraxinus ornus L. Fitoterapia 2001; 72: 471-480.
28. Pistelli L, Bertoli A, Bilia AR, Morelli I. Minor constituents from Bupleurum fruticosum rotts. Phytochemistry 1996; 41: 1579-1782.
29. Yamamoto M, Kumagai A, Yamamura Y. Arzneim-Forsch/Drug Res 1976; 25: 1021.
30. Wang ZT, Ng TB, Xu GJ. Recent advances in pharmacognosy research in China. Gen Pharmac 1995; 26: 1211-1224.
31. Huang HC, Chu SH, Lee Chao PD. Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol 1991; 198: 211-213.
32. Huang HC, Lee CR, Weng YI, Lee MC, Lee YT. Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. Eur J Pharmacol 1992; 218: 123-128.
33. Ko FN, Wu TS, Lion MJ, Huang TF, Teng CM. Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens. Eur J Pharmacol 1992; 219: 29-34.
34. Resch M, Steigel A, Chen Z, Bauer R. 5-Lipoxygenase and Cyclooxygenase-1 Inhibitory Active Compounds from Atractylodes lancea. J Nat Prod 1998; 61: 347-350.
35. Delgado G. et al. Anti-inflammatory Constituents from Heterotheca inuloides. J Nat Prod 2001; 64: 861-864.
36. Hiermann A, Schantl D, Schubert-Zsilavecz M, Reiner J. Coumarins from Peucedanum ostruthium. Phytochemistry 1996; 43: 881-883.
37. Dubois MA, Wierer M, Wagner H. Palustroside, a coumarin glucoside ester from Ledum palustre. Phytochemistry 1990; 29: 3379-3371.
38. Al Yousuf MH, Bashir AK, Blunden G, Yang MH, Patel AV. Coumarleucasin and leucasone from Leucas inflate roots. Phytochemistry 1999; 51: 95-98.
39. Gu Z, Zhang D, Yang X, Hattori M, Namba T. Isolation of two new coumarin glycosides from Notopterygium forbesii and evaluation of a Chinese crude drug, Qiang-Huo, the underground parts of N. incisum and N. forbesii, by High-Performance Liquid Chromatography. Chem Pharm Bull 1990; 38: 2498-2502.
40. Aboutabl EA, Nassar MI, Elsakhawy FM, Maklad YA, Osman AF, El-Khrisy EAM. Phytochemical and pharmacological studies on Sideritis taurica Stephan ex Wild. J Ethnophapmacology 2002; 82: 177-184.
41. Adjangba MS, Asomaning WA, Barranco A, Bone RT, Phillips WR. Pharmacological activity of coumarins isolated from Afraegle paniculata; Part II. West African. J Pharmacol Drug Res 1975; 2: 83-86; Chem Abstrs 1976; 85, 103960x.
42. Carcia-Argaez AN, Ramirez A, Teresa O, Delgado HP, Velazquez G, Martinez-Vazquez M. Anti-inflammatory activity of coumarins from Decatropis bicolor on TPA ear mice model. Planta Med 2000; 66: 279-281.
43. Tandan SK, Chandra S, Tripathi HC, Lal J. Pharmacological actions of seselin, a coumarin from Seseli indicum seeds. Fitoterapia 1990; 61: 360-363.
44. Mulholland DA, et al. Coumarins from Cedrelopsis grevei (Ptaeroxylaceae). Phytochemistry 2002; 61: 919-922.
45. Koorkanally NA, Randrianarivelojosia M, Mulholland DA, Van Ufford LQ, Van der Berg AJJ. Bioactive constituents of Cedrelopsis microfoliata. J Nat Prod 2002; 65: 1349-1352.
46. Bhalla TN, Saxena RC, Nigam SK, Mistra G, Bhargava KP. Calophyllolide- a new non-steroidal anti-inflammatory agent. Indian J Med Res 1980; 72: 762-765.
47. Chaturvedi AK, Parmar SS, Bhatnagar SC, Mistra G, Nigam SK. Anticonvulsant and anti-inflammatory activity of natural plant coumarins and triterpenoids. Res Commun Chem Pathol Pharmacol 1974; 9: 11-22; Chem Abstrs 1975; 82: 38600b.
48. Hepworth JD. In: Katritzky AR, Rees CW Ed, Comprehensive Heterocyclic Chemistry. Oxford, Pergamon Press 1984; Vol 3, 737-883;
49. Hepwoth JD, Gabbut CD, Heron BM. In: McKillop A Ed, Comprehensive Heterocyclic Chemistry, 2nd Ed. Oxford, Pergamon Press 1996; Vol 5, 351-468.
50. Litinas KE, Nicolaides DN, Varella EA. A convenient synthesis of 3-aryl-4H-[1]benzopyrano[3,4-d]isoxazol-4-ones. J. Heterocyclic Chem. 1990; 27: 769-774;
51. Harayama T, Nakatsuka K, Nishioka H, Murakami K, Hayashida N, Ishii H. Chem Pharm Bull 1994: 42: 2170-2173.
52. Chatterjee AK, Toste FD, Goldberg SD, Grubbs RH. Synthesis of coumarins by ring-closing metathesis. Pure Appl Chem 2003; 75: 421-425.
53. 11-Catalyzed reaction of phenols with propiolic esters. A single-step synthesis of coumarins. Bull Chem See Jpn 2003; 76:1889-1895.
54. Fylaktakidou KC, Gautam DR, Hadjipavlou-Litina DJ, Kontogiorgis CA, Litinas KE, Nicolaides DN. Reactions of 4-methylchromene-2,7,8-trione with phosphonium ylides. Synthesis and evaluation of fused 1, 3-dioxolocoumarins as antioxidants and antiinflammatories. J Chem Soc Perkin Trans 1 2001; 3073-3079.
55. Geigy JR. 4-Aminocoumarins. Belg Patent 1962; 610, 413; Chem Abstrs 1963; 58: 1436.
56. Deshmukh SY, Kelkar SL, Wadia MS. A one step synthesis of 3-benzylcoumarins. Synth Commun 1990; 20: 855-863.
57. Kontogiorgis CA, Hadjipavlou-Litina DJ. Synthesis and biological evaluation of novel coumarin derivatives with a 7-azomethine linkage. Bioorg Med Chem Lett 2004; 14: 611-614.
58. Bonsignore L, Loy G, Secci D, Calignano A. Synthesis and pharmacological activity of 2-oxo-(2H)-1-benzopyran-3-carboxamide derivatives. Eur J Med Chem 1993; 28: 517-520.
59. Artizzu N, Bonsignore L, Loy G. N-Substituted 2-oxo-(2H)1-benzopyran-3-carboxamide derivatives with analgesic and/or diuretic activities. Il Farmaco 1995; 50: 853-856,
60. Bylov IE, Vasylyev MV, Bilokin YV. Synthesis and anti-inflammatory activity of N-substituted 2-oxo-2H-1-benzopyran-3-carboxamides and their 2-iminoanalogues. Eur J Med Chem 1999; 34: 997-1001.
61. Ghate M, Manohar D, Kulkarni V, Shobha R, Kattimani SY. Synthesis of vanillin ethers from 4-(bromomethyl)coumarins as anti-inflammatory agents. Eur J Med Chem 2003; 38: 297-302.
62. Nicolaides DN, Fylaktakidou KC, Litinas KE, Hadjipavlou-Litina D. Synthesis and biological evaluation of some 4-(isoxazolinyl or 1,2,4-oxadiazolyl) coumarins. J Heterocyclic Chem 1996; 33: 967-971.
63. Nicolaides DN, Fylaktakidou KC, Litinas KE, Papageorgiou GK, Hadjipavlou-Litina DJ. 1,3-Cycloaddition reactions of 2-oxo-2H-[1]benzopyran-4-carbonitrile N-oxide. Synthesis of several new 4-substituted coumarins. J Heterocyclic Chem 1998; 35: 619-625.
64. Emmanuel-Giotta AA, Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Synthesis and biological evaluation of several 3-(coumarin-4-yl)tetrahydroisoxazole and 3-(coumarin-4-yl)dihydropyrazole derivatives. J Heterocyclic Chem 2001; 38: 717-722.
65. Nicolaides DN, Fylaktakidou KC, Litinas KE, Hadjipavlou-Litina D. Synthesis and biological evaluation of several coumarin-4-carboxamidoxime and 3-(coumarin-4-yl)-1,2,4-oxadiazole derivatives. Eur J Med Chem 1998; 33: 715-724.
66. Hanmantgad SS, Kulkarni MV, Patil VD. Biomimetic thiazolyl coumarins. Nat Acad Sci Lett (India) 1984; 7: 77-78; Chem Abstrs 1985; 103, 53986c.
67. Mayer RJ. Coumarin compounds for their anti-inflammatory activities. WO Patent 1996, 9606611; Chem Abstrs 1996; 125, P1381m.
68. Friesen R, Dube D, Ducharme Y, Lepine C, Delorme D, Hamel P. Preparation of bis[bi(aryl/heteroaryl)] compounds as inhibitors of leukotriene biosynthesis. Can Patent 1996; 2169231; US Patent 1996, 5576338; Chem Abstrs 1997; 126, P212053q.
69. Maddi V, Raghu KS, Rao MNA. Synthesis and anti-inflammatory activity of 3-(benzylideneamino)coumarins in rodents. J Pharm Sci 1992; 81: 964-966.
70. Hadjipavlou-Litina DJ. New diaminoether coumarinic derivatives with anti-inflammatory activity. Arzneim-Forsch/Drug Res 2000; 50(II): 631-635.
71. Takemura Y, Ikeda Y, Niimura K. Preparation of coumarin derivatives and glycosides. Jap. Patent 1998; WO Patent 9804572; Chem Abstrs 1998; 128, P140965e.
72. Hashimoto K, Yamada A, Hamano H, Mori S, Moriuchi H. Preparation of coumarin derivatives as 12-lipoxygenase inhibitors. Jap. Patent 1994; WO Patent 9424119; Chem Abstrs 1995; 122, P213929j.
73. 2 System and their potent bioactivities. Biochem Biophys Res Commun 1990; 168: 169-175.
74. Nicolaides DN, Bezergiannidou-Balouctsi C, Litinas KE, Malamidou-Xenikaki E, Mentzafos D, Terzis A. I-8H-Pyrano[3,2-g]benzoxazol-8-ones from 7-methoxyimino-4-methylehromene-2,8-dione. Tetrahedron 1993; 49: 9127-9136.
75. Bezergiannidou-Balouctsi C, Litinas KE, Malamidou-Xenikaki E, Nicolaides DN. Reactions of 7-(methoxyimino)-4-methyl-2H-chromene-2,8(7H)-dione with phosphorus ylides. Synthesis of 2-substituted 6-methyl-8H-[1]benzopyrano[7,8-d]oxazol-8-ones. Liebigs Ann Chem 1993; 1175-1177.
76. Kontogiorgis C, Hadjipavlou-Litina D. Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory/antioxidant agents. J Enz Inhib Med Chem 2003; 18: 63-69.
77. Khan K, et al. Synthesis, antioxidant and insecticidal activities of some coumarin derivatives. J Chem Soc Pakistan 2002; 24: 226-231; Chem Abstrs 2003; 138, 255056.
78. Prosdocimi M, Menon G, Monastra G, Galbiati E, Finesso M. Preparation of coumarin derivatives and their pharmaceutical use. WO Patent 2002, 2002010I48; Chem Abstrs 2002; 136, P167212.
79. Cheng JF, et al. Preparation of coumarin derivatives useful as TNFa inhibitors. WO Patent 2002; 2002008217; Chem Abstrs 2002; 136, P151035
80. Cuzzocrea S, et al. Cloricromene, a coumarin derivative, protects against collagen-induced arthritis in Lewis rats. Br J Pharmacol 2000; 131: 1399-1407.
81. Nicolaides DN, Bezergiannidou-Balouctsi C, Litinas KE, Malamidou-Xenikaki, E, Mentzafos D, Terzis A. Reactions of 4-methylchromene-2,7,8-trione with phosphorus ylides. Synthesis of coumarins 7,8-fused onto furan, pyran and dioxole rings. J Chem Research (M) 1993; 826-851.
82. Mosti L, et al. Synthesis of angelicin heteroanalogues: preliminary photobiological and pharmacological studies. Il Farmaco 1998; 53: 602-610.
83. Nicolaides DN, Fylaktakidou KC, Bezergiannidou-Balouctsi C, Litinas KE. Reactions of 4,6-bis(acetyl)resorcinol with alkoxycarbonylalkylidene(triphenyl)phosphoranes. Preparation of coumarin derivatives. J Heterocyclic Chem 1994; 31: 173-176.
84. Palmer CJ, Josephs JL. Synthesis of the Calophyllum coumarins. Part 2. J Chem Soc Perkin Trans 1 1995; 3135-3152.
85. Alcaraz MJ, Fernandez P, Guillen MI. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Design 2003; 9(30): 2541-51.
86. Kitts DD, Weiler K. Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Curr Pharm Design 2003; 9(16): 1309-23.
87. Perrella M A, Yet SF. Role of heme oxygenase-1 in cardiovascular function. Curr Pharm Design 2003; 9(30): 2479-87.